Li Shen Loo

1.6k total citations
24 papers, 993 citations indexed

About

Li Shen Loo is a scholar working on Molecular Biology, Psychiatry and Mental health and Cell Biology. According to data from OpenAlex, Li Shen Loo has authored 24 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Psychiatry and Mental health and 7 papers in Cell Biology. Recurrent topics in Li Shen Loo's work include Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Li Shen Loo is often cited by papers focused on Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Li Shen Loo collaborates with scholars based in United States, Singapore and Germany. Li Shen Loo's co-authors include Wanjin Hong, Chun Jye Lim, Yaan Fun Chong, Siew Wee Chan, Caixia Huang, Yan Shan Ong, Lei Cai, Gavin S. Dawe, Ning Tang and Brendon J. Hanson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

In The Last Decade

Li Shen Loo

24 papers receiving 977 citations

Peers

Li Shen Loo
Ian M. Williams United Kingdom
Uttio Roy Chowdhury United States
Bitao Bu China
Tyler Mark Pierson United States
Zofia M. Lasiecka United States
Joanne Wuu United States
Li Shen Loo
Citations per year, relative to Li Shen Loo Li Shen Loo (= 1×) peers Selma A. Serra

Countries citing papers authored by Li Shen Loo

Since Specialization
Citations

This map shows the geographic impact of Li Shen Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Shen Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Shen Loo more than expected).

Fields of papers citing papers by Li Shen Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Shen Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Shen Loo. The network helps show where Li Shen Loo may publish in the future.

Co-authorship network of co-authors of Li Shen Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Li Shen Loo. A scholar is included among the top collaborators of Li Shen Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Shen Loo. Li Shen Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montalbán, Xavier, Patrick Vermersch, Douglas L. Arnold, et al.. (2024). Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials. The Lancet Neurology. 23(11). 1119–1132. 32 indexed citations
2.
Lim, Jean K., et al.. (2023). Practical Applications of a Nausea and Vomiting Model in the Clinical Development of Additional Doses of Dulaglutide. The Journal of Clinical Pharmacology. 64(2). 215–226. 1 indexed citations
3.
Lipton, Richard B., Simin Baygani, Stewart J. Tepper, et al.. (2021). A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN. The Journal of Headache and Pain. 22(1). 101–101. 2 indexed citations
5.
Leroux, Élizabeth, Andrew Buchanan, Louise Lombard, et al.. (2020). Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review. Advances in Therapy. 37(12). 4765–4796. 39 indexed citations
6.
Lipton, Richard B., Louise Lombard, Dustin Ruff, et al.. (2020). Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study. The Journal of Headache and Pain. 21(1). 20–20. 30 indexed citations
7.
Lipton, Richard B., Li Shen Loo, Andre B. Araujo, et al.. (2020). Migraine and Functional Impairment Associated with Driving: Results of the OVERCOME Study (1638). Neurology. 94(15_supplement). 1 indexed citations
8.
Loo, Li Shen, Ira Turner, Michael Case, et al.. (2019). Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN). BMC Neurology. 19(1). 191–191. 24 indexed citations
9.
Loo, Li Shen, Jessica Ailani, Jack Schim, et al.. (2019). Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials. The Journal of Headache and Pain. 20(1). 84–84. 30 indexed citations
10.
Knievel, Kerry, Andrew Buchanan, Louise Lombard, et al.. (2019). Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans. Cephalalgia. 40(1). 19–27. 40 indexed citations
11.
Tello‐Lafoz, María, Li Shen Loo, Wanjin Hong, et al.. (2017). SNX27 links DGKζ to the control of transcriptional and metabolic programs in T lymphocytes. Scientific Reports. 7(1). 16361–16361. 14 indexed citations
12.
Chan, Audrey, Thomas Clairfeuille, Euphemie Landao‐Bassonga, et al.. (2016). Sorting nexin 27 couples PTHR trafficking to retromer for signal regulation in osteoblasts during bone growth. Molecular Biology of the Cell. 27(8). 1367–1382. 41 indexed citations
13.
Chakraborty, Sayan, Manikandan Lakshmanan, Jianxiang Chen, et al.. (2015). An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma. Nature Communications. 6(1). 6184–6184. 126 indexed citations
14.
Loo, Li Shen, Ning Tang, Muthafar Al‐Haddawi, Gavin S. Dawe, & Wanjin Hong. (2014). A role for sorting nexin 27 in AMPA receptor trafficking. Nature Communications. 5(1). 3176–3176. 80 indexed citations
15.
Loo, Li Shen, et al.. (2009). A role for endobrevin/VAMP8 in CTL lytic granule exocytosis. European Journal of Immunology. 39(12). 3520–3528. 35 indexed citations
16.
Loo, Li Shen, et al.. (2009). Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor. The EMBO Journal. 28(22). 3485–3499. 26 indexed citations
17.
Chan, Siew Wee, Chun Jye Lim, Li Shen Loo, et al.. (2009). TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation. Journal of Biological Chemistry. 284(21). 14347–14358. 216 indexed citations
18.
Loo, Li Shen & James O McNamara. (2006). Impaired Volume Regulation is the Mechanism of Excitotoxic Sensitization to Complement. Journal of Neuroscience. 26(40). 10177–10187. 7 indexed citations
19.
Berglund, Ken, Patrik Krieger, Li Shen Loo, et al.. (2006). Imaging synaptic inhibition in transgenic mice expressing the chloride indicator, Clomeleon. PubMed. 35(4-6). 207–228. 67 indexed citations
20.
Loo, Li Shen, et al.. (2002). Cortical expression of endothelin receptor subtypes A and B following middle cerebral artery occlusion in rats. Neuroscience. 112(4). 993–1000. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026